Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-20110 Combination Therapies in Advanced Colorectal Cancer
NCT07283367Phase 2Recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Dec 2025
- Primary completion
- Dec 2029
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of HS-20110 in colorectal cancer (CRC), sponsored by Hansoh Pharmaceutical Group. Started Dec 2025; status: recruiting.
02
Drugs
HS-20110
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07283367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07283367.